BioNTech SE (BNTX) Research & Development (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Research & Development data on file, last reported at -$588.3 million in Q4 2025.

• For the quarter ending Q4 2025, Research & Development rose 10.01% year-over-year to -$588.3 million; the trailing twelve-month figure through Dec 2025 stood at -$2.4 billion (up 2.51% YoY), and the FY2025 full-year result was -$2.4 billion, up 1.27% from the prior year.
• Research & Development improved to -$588.3 million in Q4 2025, from -$660.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of -$242.2 million in Q2 2021 to a low of -$660.3 million in Q3 2025.
• A 5-year average of -$473.9 million and a median of -$531.1 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development tumbled 101360660.56% in 2021 and advanced 10.01% in 2025, its largest moves.
• Tracing BNTX's Research & Development over 5 years: stood at -$310.6 million in 2021, then sank by 67.46% to -$520.1 million in 2022, then slipped by 19.53% to -$621.7 million in 2023, then declined by 5.16% to -$653.8 million in 2024, then gained by 10.01% to -$588.3 million in 2025.
• Business Quant data shows BNTX's Research & Development at -$588.3 million in Q4 2025, -$660.3 million in Q3 2025, and -$576.3 million in Q2 2025.